SelectQuote, Inc. (NYSE: SLQT) announced the formation of a
Healthcare Advisory Board to help the company strengthen the
mission and clinical strategy of Population Health. This group of
world-class experts will advise Population Health on ways to
empower, engage and educate consumers on healthcare solutions and
benefits, equipping them to lead healthier lives through improved
health outcomes while reducing costs for patients and the
healthcare system. This group of world-renowned leaders brings
comprehensive healthcare expertise from the pharmaceutical, health
IT, payer, provider, and regulatory market segments and will
provide important insight and expertise to help shape continuing
innovation and growth at Population Health.
“We are excited to welcome such distinguished industry leaders
as the inaugural members of our Healthcare Advisory Board. The
development of our Healthcare Advisory Board is the next step in
expanding Population Health and the services we offer through this
platform,” said Bob Grant, SelectQuote President. “The Advisory
Board consists of highly sought after members of the healthcare
community who can provide insights and recommendations on
Population Health’s strategy, objectives and partnerships. These
deeply experienced individuals bring unparalleled expertise in
healthcare, and we are excited they see that our vision for
Population Health is both achievable and an important step forward
for the future of healthcare.”
The Advisory Board will be led by SelectQuote Board members
Kavita Patel, MD and Earl “Trace” Devanny. Advisory
Board members include:
Basit Chaudhry, MD is an internal medicine physician and
medical technologist who founded Tuple Health in 2013. His
expertise spans healthcare payment, clinical service redesign, and
the use of data analytics to improve clinical and financial
performance in healthcare.
Alan Muney, MD is currently an external advisor to Bain
& Company, and a Senior Advisor for Pritzker Private Capital,
NEA and Arsenal Capital Partners. From 2010 to 2018, he was the
Executive Vice President and Chief Medical Officer for Cigna,
leading the company’s health management and network contracting
activities.
Joe Grogan is a former Assistant to the President,
Director of the Domestic Policy Council and Associate Director,
Health Programs for the Office of Management and Budget. He is
currently a Fellow with the USC Schaeffer Center. He has served at
senior management roles at Amgen, Inc., and Gilead Sciences, Inc.,
and he has an extensive background working with the FDA on
regulatory, legislative and policy initiatives.
Rebekah Gee, MD is the President and Founder of Nest
Health and CEO of Healthcare Services for LSU Health. She formerly
served as Secretary of the Louisiana Department of Health, the
state’s largest agency. She is a policy expert and is widely
published in health services research, and has served in numerous
additional state and national policy roles.
Dr. Patel is currently a Fellow with the Brookings
Institute and served in the Obama Administration as Director of
Policy for the Office of Intergovernmental Affairs and Public
Engagement. She is also an advisor to the Bipartisan Policy Center
and a member of Health and Human Services Physician Focused Payment
Model Technical Advisory Committee.
Devanny is the former CEO of Tract Manager, a provider of
healthcare strategic sourcing and compliance application suites.
From 2014 to 2016, he served as President of Nuance Communications’
healthcare business. He has also led healthcare company Trizetto
Corporation and health information technology company Cerner
Corporation.
"The Advisory Board’s expertise spans payers, policy,
technology, providers and patients. It is an incredible group that
will help make a meaningful impact on the Population Health work of
SelectQuote," said Dr. Patel. "I look forward to working with the
Advisory Board to make an impactful difference in how we view
healthcare."
The Advisory Board will report directly to a newly formed
standing committee of SelectQuote’s Board of Directors.
Forward Looking Statement
This release contains forward-looking statements. These
forward-looking statements reflect our current views with respect
to, among other things, future events and our financial
performance. These statements are often, but not always, made
through the use of words or phrases such as “may,” “should,”
“could,” “predict,” “potential,” “believe,” “will likely result,”
“expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,”
“intend,” “plan,” “projection,” “would” and “outlook,” or the
negative version of those words or other comparable words or
phrases of a future or forward-looking nature. These
forward-looking statements are not historical facts, and are based
on current expectations, estimates and projections about our
industry, management’s beliefs and certain assumptions made by
management, many of which, by their nature, are inherently
uncertain and beyond our control. Accordingly, we caution you that
any such forward-looking statements are not guarantees of future
performance and are subject to risks, assumptions and uncertainties
that are difficult to predict. Although we believe that the
expectations reflected in these forward-looking statements are
reasonable as of the date made, actual results may prove to be
materially different from the results expressed or implied by the
forward-looking statements.
Our actual results to differ materially from those indicated in
these forward-looking statements due to a number of important
factors, including, but not limited to, the following: the ultimate
duration and impact of the ongoing COVID-19 pandemic; our reliance
on a limited number of insurance carrier partners and any potential
termination of those relationships or failure to develop new
relationships; existing and future laws and regulations affecting
the health insurance market; changes in health insurance products
offered by our insurance carrier partners and the health insurance
market generally; insurance carriers offering products and services
directly to consumers; changes to commissions paid by insurance
carriers and underwriting practices; competition with brokers,
exclusively online brokers and carriers who opt to sell policies
directly to consumers; competition from government-run health
insurance exchanges; developments in the U.S. health insurance
system; our dependence on revenue from carriers in our senior
segment and downturns in the senior health as well as life,
automotive and home insurance industries; our ability to develop
new offerings and penetrate new vertical markets; risks from
third-party products; failure to enroll individuals during the
Medicare annual enrollment period; our ability to attract,
integrate and retain qualified personnel; our dependence on lead
providers and ability to compete for leads; failure to obtain
and/or convert sales leads to actual sales of insurance policies;
access to data from consumers and insurance carriers; accuracy of
information provided from and to consumers during the insurance
shopping process; cost-effective advertisement through internet
search engines; ability to contact consumers and market products by
telephone; global economic conditions; disruption to operations as
a result of future acquisitions; significant estimates and
assumptions in the preparation of our financial statements;
impairment of goodwill; potential litigation and claims, including
IP litigation; our existing and future indebtedness; developments
with respect to LIBOR; access to additional capital; failure to
protect our intellectual property and our brand; fluctuations in
our financial results caused by seasonality; accuracy and
timeliness of commissions reports from insurance carriers; timing
of insurance carriers’ approval and payment practices; factors that
impact our estimate of the constrained lifetime value of
commissions per policyholder; changes in accounting rules, tax
legislation and other legislation; disruptions or failures of our
technological infrastructure and platform; failure to maintain
relationships with third-party service providers; cybersecurity
breaches or other attacks involving our systems or those of our
insurance carrier partners or third-party service providers; our
ability to protect consumer information and other data; and failure
to market and sell Medicare plans effectively or in compliance with
laws. For a further discussion of these and other risk factors that
could impact our future results and performance, see the section
entitled “Risk Factors” in our most recent Annual Report on Form
10-K that we have filed with the Securities and Exchange
Commission, and our subsequent filings with the Securities and
Exchange Commission. Accordingly, you should not place undue
reliance on any such forward-looking statements. Any
forward-looking statement speaks only as of the date on which it is
made, and, except as otherwise required by law, we do not undertake
any obligation to publicly update or review any forward-looking
statement, whether as a result of new information, future
developments or otherwise.
About SelectQuote:
Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions
that help consumers protect their most valuable assets: their
families, health and property. SelectQuote pioneered the model of
providing unbiased comparisons from multiple, highly-rated
insurance companies allowing consumers to choose the policy and
terms that best meet their unique needs. Two foundational pillars
underpin the company’s success: a strong force of highly-trained
and skilled agents who provide a consultative needs analysis for
every consumer, and proprietary technology that sources and routes
high-quality leads. SelectQuote has three core business lines:
SelectQuote Senior, SelectQuote Life and SelectQuote Auto and Home.
SelectQuote Senior, the largest and fastest-growing business,
serves the needs of a demographic that sees 10,000 people turn 65
each day with a range of Medicare Advantage and Medicare Supplement
plans. In 2021, SelectQuote expanded its business with the addition
of Population Health, a healthcare services company, and SelectRx,
a specialty medication management pharmacy.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220301005393/en/
Media: Kelly Hale Communications Manager SelectQuote, Inc.
kelly.hale@selectquote.com O: 913.894.5569
Matt Gunter Communications and Investor Relations SelectQuote,
Inc. matt.gunter@selectquote.com O: 913.286.4931
SelectQuote (NYSE:SLQT)
Historical Stock Chart
From Mar 2024 to Apr 2024
SelectQuote (NYSE:SLQT)
Historical Stock Chart
From Apr 2023 to Apr 2024